{"id":"W2075213874","doi":"10.1056/nejmoa043681","title":"Adjuvant Docetaxel for Node-Positive Breast Cancer","year":2005,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":952,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Health Economics; Sault Area Hospital; Dr. Georges-L.-Dumont University Hospital Centre; Hôpital du Saint-Sacrement; Hôpital Saint-Luc; Nova Scotia Cancer Centre; Saskatchewan Cancer Agency; Ottawa Regional Cancer Foundation","funders":"Association of Medical Research Charities; Canadian Breast Cancer Research Alliance; GlaxoSmithKline; Amgen; Pfizer; Genentech; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Docetaxel; Adjuvant; Breast cancer; Oncology; Internal medicine; Cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006345868,0.0002076086,0.0004671795,0.0002331503,0.0001437881,0.0002454914,0.000205483,0.0002369956,0.001491463],"category_scores_gemma":[0.001131803,0.00008736509,0.0003058465,0.0001974236,0.0001935358,0.0001162788,0.0001173222,0.0004886918,0.0001939807],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004546716,"about_ca_system_score_gemma":0.0006063374,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008067452,"about_ca_topic_score_gemma":0.002612071,"domain_scores_codex":[0.9997653,0.0001125476,0.00002131154,0.00002548624,0.00004183039,0.00003352612],"domain_scores_gemma":[0.9996029,0.0001683886,0.000073015,0.00001819957,0.00001942748,0.0001181665],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2555728,0.01124148,0.02877251,0.00267626,0.00114302,0.0006303966,0.0002233419,0.008262833,0.01594844,0.0008849419,0.003627573,0.6710164],"study_design_scores_gemma":[0.2025902,0.5883318,0.1033983,0.001363216,0.003629328,0.004636687,0.0002199785,0.007804222,0.01660193,0.00172846,0.06961359,0.00008227178],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9680998,0.02798053,0.0003106961,0.0004878283,0.0002599711,0.0003234091,0.0001523922,0.00001522183,0.002370122],"genre_scores_gemma":[0.9923791,0.005887017,0.0004399635,0.0002201716,0.00009050839,0.0001056941,0.000177082,0.000002186124,0.0006983679],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001491463,"threshold_uncertainty_score":0.004989445,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009921351495374873,"score_gpt":0.2840717143014677,"score_spread":0.2741503628060928,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}